Malignant Blood Vessel Neoplasm — Trials

Malignant Blood Vessel Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

191 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 36
Recruiting: 22
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 51–100 of 191 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05846724	Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma(PULSAR)	withdrawn	Phase 2	0	Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER	0	Jan 22, 2026	clinicaltrials
NCT02408861	Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	terminated	Phase 1	79	National Cancer Institute (NCI)NIH